검색어 : 통합검색[579.2]
총 1,436건 중 1,000건 출력
, 2/100 페이지
-
11
- Evaluation of the API 579-1/ASME FFS-1 KSSCCL1 and KSSCCL2 Stress Intensity Factors
- Altstadt, Steven; Sarzynski, Melanie; Wiss, Janney, Elstner Associates, Inc. , Northbrook, Illinois, United States; Wiss, Janney, Elstner Associates, Inc. , Northbrook, Illinois, United States; (Volume 2: Computer Technology & Bolted Joints; Design & Analysis, v.2023, 2023, pp.V002T03A046)
-
12
- 579 Intracervical dinoprostone (PGE2): Does it actually lower the cesarean section rate?
- ; ; (American journal of obstetrics and gynecology, v.164, 1991, pp.405)
-
13
- Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats
- Houghton, Andrea K; Parsons, Chris G; Headley, P.Max; ; (Pain, v.91, 2001, pp.201-207)
-
14
- 17 cases with subungual hematoma treated by CO<SUB>2</SUB> laser [2887-579]
- Deng, D.; ; (Proceedings of SPIE--the international society for optical engineering, v.2887, 1996, pp.17-19)
-
15
- 579 Diffuse non-ischemic microvascular disease in asymptomatic patients with type 2 diabetes
- Schmidt, A.; Lau, D.; Friedrich, M.; ; (The Canadian journal of cardiology, v.27, 2011, pp.S271)
-
16
- 579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine
- Schultheis, Katherine; Reed, Charles C; Andrade, Viviane M; Kalia, Richa; Tur, Jared; Schouest, Blake; Elwood, Dustin; Maricic, Igor; Doan, Arthur; Eblimit, Zeena; Pezzoli, Patrick; Amante, Dinah; yang, maria; Fader, Joseph g; Ferrer, Roi; Weiner, David; Kim, J Joseph; Humeau, Laurent; Ramos, Stephanie; Smith, Trevor R F; Broderick, Kate; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; Inovio Pharmaceuticals , San Diego, California; Inovio Pharmaceuticals , San Diego, California; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; Inovio Pharmaceuticals , San Diego, California; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; Inovio , San Diego, California; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharamceuticals , San Diego, California; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; Inovio , San Diego, California; Inovio , San Diego, California; Inovio , San Diego, California; Wistar Institute , Philadelphia, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, Pennsylvania; INOVIO Pharmaceuticals , Plymouth Meeting, P; (Open forum infectious diseases, v.8, 2021, pp.S391-S392)
-
17
- Partial agonism and fast dissociation of LASSBio-579 at dopamine D<sub>2</sub> receptor
- Pompeu, T.E.T.; Monteiro do Monte, F.; Bosier, B.; Fraga, C.A.M.; Barreiro, E.J.; Menegatti, R.; Hermans, E.; Noel, F.; ; (Progress in neuro-psychopharmacology & biological psychiatry, v.62, 2015, pp.1-6)
-
18
- An SMA-actuated Implantable System for Delivery of Liquid Drugs (BRE2-579)
- Reynaerts, D.; Peirs, J.; Van Brussel, H.; ; (New actuators, v.1996, 1996, pp.379-382)
-
19
- Epidemiological, Otolaryngological, Olfactory and Gustatory Outcomes According to the Severity of COVID-19: A study of 2,579 Patients. | Epidemiological, Otolaryngological, Olfactory and Gustatory Outcomes According to the Severity of COVID-19: A study of 2,579 Patients.
- Lechien Jerome; Chiesa-Estomba Carlos; Vaira Luigi; Riu Giacomo De; Cammaroto Giovanni; Idrissi Younes Chekkoury; Circiu Marta; Distinguin Lea; journe fabrice; Terwangne Christophe de; machayekhi shahram; Barillari Maria; Calvo-Henriquez Christian; Hans Stephane; Saussez Sven; Universite de Mons; Hospital Universitario de Donostia; Sassari University Hospital; Sassari University Hospital; Ospedale Morgagni-Pierantoni; Foch; Hospital Foch; Hospital Foch; CHU Saint-Pierre; Hospital Centre EpiCURA; Hospital Centre EpiCURA; Second University of Napoli Department of Environmental Biological and Pharmaceutical Sciences and Technologies; Hospital Complex of Santiago de Compostela; Foch; UMONS; (, v., 2020, )
-
20
- MiR-579 Inhibits Lung Adenocarcinoma Cell Proliferation and Metastasis via Binding to CRABP2
- Yi, Qijun; Miao, Yu'e; Kong, Ying; Xu, Yan; Zhou, Jinghao; Dong, Qi; Liu, Haiyan; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; Department of Chemotherapy, The Second Affiliated Hospital of Shandong First Medical University, Tai'an City, Shandong, China; (Computational and mathematical methods in medicine : CMMM, v.2022, 2022, pp.9111681)
QUICK MENU
